Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...
CRISPR Therapeutics AG (CRSP) closed at $41.17 in the latest trading session, marking a -1.84% move from the prior day. Biotech is an area that may offer your portfolio growth today and earnings ...
After hours: March 21 at 7:54:03 PM EDT ...
After hours: 7:46:56 p.m. EDT Loading Chart for CRSP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback